Skip to main content

BMA ANNUAL REPRESENTATIVE MEETING MOTIONS ON HOMEOPATHY

EDM (Early Day Motion) 284: tabled on 21 June 2010

Tabled in the 2010-12 session.

This motion has been signed by 27 Members. It has received 1 amendment.

As this motion is using historical data, we may not have the record of the original ordering, in which case signatories are listed alphabetically.

Amendment to this motion

There has been an amendment submitted to this motion.

View details of the amendment

Motion text

That this House expresses concern at motions 301, 301a, 301b, 301c, 301d, 301e and 301f at this year's British Medical Association's (BMA) Annual Representative Meeting, which calls for no further commissioning of, nor funding for, homeopathic remedies in the NHS; believes that the BMA has overstepped its remit by making such statements without proper consultation with its own membership that practice homeopathy and, more importantly, with the tens of thousands of patients who depend on homeopathy; thinks that an integrated NHS, which employs the best from the orthodox and complementary, and which empowers patients, could deliver better and more cost-effective outcomes at a time of financial prudence; and calls on the Government to maintain its policy of allowing decision-making on individual clinical interventions, including homeopathy, to remain in the hands of local NHS service providers and practitioners who are best placed to know their community's needs.

The first 6 Members who have signed to support the motion are the sponsors. The primary sponsor is generally the person who tabled the motion and has responsibility for it. The date shown is when the Member signed the motion.

In addition to the sponsors, the following Members have signed to support the motion.

After a motion has been tabled, other Members can table amendments to it. Amendments to this motion are shown below.

BMA ANNUAL REPRESENTATIVE MEETING MOTIONS ON HOMEOPATHY (Amendment 1)
leave out from `expresses' to end and insert `support for the right of the BMA to express its views about the efficacy and cost-effectiveness of any putative health treatment and the appropriateness of the NHS commissioning such treatments; notes that the motions of the 2010 BMA Annual Representative Meeting dealing with homeopathy endorse the findings of the recent report from the Fourth Report of the Science and Technology Select Committee of Session 2009-10 on Evidence Check 2: Homeopathy Fourth Report of Session, HC45, namely that the evidence base is clear that homeopathy is not effective beyond placebo and that scarce NHS funds should not be spent commissioning it at a time when, due to cost, the health service is not able to provide its patients even with treatments that have been shown to be effective in clinical trials; and further welcomes the view of the BMA that healthcare should be based on good evidence of effectiveness and cost-effectiveness.'.
Liberal Democrat, Cambridge
11
signatures
EDM 284A1: tabled on 24 June 2010